Evidence map›Paper›PMID 29927013›Full record

ArticlePsycho-oncology2018

Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.

Femke Jansen, Irma M Verdonck-de Leeuw, Pim Cuijpers, C René Leemans, Tim Waterboer, Michael Pawlita, Chris Penfold, Steven J Thomas, Andrea Waylen, Andrew R Ness

Open access · hybridAbstract read
In one paragraph

Article in Psycho-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Development of depression in patients with oropharyngeal cancer: a systematic review.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Survivorship therapy needs after radiotherapy for head and neck cancer: surveying opportunities for growth (STRONG).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. The effect of psychological condition before radiotherapy on prognosis in 390 patients initially treated for nasopharyngeal carcinoma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Femke JansenDepartment of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-0111-0557
Irma M Verdonck-de LeeuwDepartment of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.
Pim CuijpersDepartment of Clinical, Neuro and Development Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
C René LeemansDepartment of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.
Tim WaterboerMolecular Diagnostics of Oncogenic Infections Division, German Cancer Research Center (DFKZ), Heidelberg, Germany.
Michael PawlitaMolecular Diagnostics of Oncogenic Infections Division, German Cancer Research Center (DFKZ), Heidelberg, Germany.
Chris PenfoldNational Institute for Health Research (NIHR) Bristol Biomedical Research Centre, the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.
Steven J ThomasSchool of Oral and Dental Sciences, University of Bristol, Bristol, UK.
Andrea WaylenSchool of Oral and Dental Sciences, University of Bristol, Bristol, UK.
Andrew R NessNational Institute for Health Research (NIHR) Bristol Biomedical Research Centre, the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.
University Of Bristol Dental Hospital · GBAmsterdam UMC Location Vrije Universiteit Amsterdam · NLGerman Cancer Research Center · DEVrije Universiteit Amsterdam · NL

Funding

Cancer Research UK 19169Cancer Research UK C18281/A19169Department of Health RP-PG-0707-10034
6 · The paper itself

Abstract

objectiveThe objective of the study is to investigate the relation between pretreatment depressive symptoms (DS) and the course of DS during the first year after cancer diagnosis, and overall survival among people with head and neck cancer (HNC).

methodsData from the Head and Neck 5000 prospective clinical cohort study were used. Depressive symptoms were measured using the Hospital Anxiety and Depression Scale (HADS) pretreatment, at 4 and 12-month follow-up. Also, socio-demographic, clinical, lifestyle, and mortality data were collected. The association between before start of treatment DS (HADS-depression > 7) and course (never DS, recovered from DS, or persistent/recurrent/late DS at 12-month follow-up) and survival was investigated using Cox regression. Unadjusted and adjusted analyses were performed.

resultsIn total, 384 of the 2144 persons (18%) reported pretreatment DS. Regarding DS course, 63% never had DS, 16% recovered, and 20% had persistent/recurrent/late DS. People with pretreatment DS had a higher risk of earlier death than people without DS (hazard ratio (HR) = 1.65; 95% confidence interval (CI) 1.33-2.05), but this decreased after correcting for socio-demographic, clinical, and lifestyle-related factors (HR = 1.21; 95% CI 0.97-1.52). Regarding the course of DS, people with persistent/recurrent/late DS had a higher risk of earlier death (HR = 2.04; 95% CI 1.36-3.05), while people who recovered had a comparable risk (HR = 1.12; 95% CI 0.66-1.90) as the reference group who never experienced DS. After correcting for socio-demographic and clinical factors, people with persistent/recurrent/late DS still had a higher risk of earlier death (HR = 1.66; 95% CI 1.09-2.53).

conclusionsPretreatment DS and persistent/recurrent/late DS were associated with worse survival among people with HNC.

Indexed as

Health StatusAdultAgedCancer SurvivorsCohort StudiesDepressionFemaleHead and Neck NeoplasmsHumansLongitudinal StudiesMaleMiddle AgedProportional Hazards ModelsProspective StudiesSocial Supportcancerdepressiondepressive symptomshead and neck cancermortalityoncologysurvival

Identifiers

PMID29927013
PMCPMC6231089
OpenAlexW2809053323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.